Mouse lymphoma cells: mechanisms of resistance to glucocorticoids. 1979

C H Sibley, and K R Yamamoto

S49, an established line of mouse lymphoma cells, has several characteristics useful for the genetic analysis of glucocorticoid action: (1) a stable pseudodiploid karyotype; (2) an efficient cytolytic effect of glucocorticoids, which appears to follow the same biochemical pathway as steroid hormone action in other systems; (3) appearance of rare steroid-insensitive clones that exhibit stable, heritable resistance to further glucocorticoid treatment; (4) rapid growth in suspension culture and high cloning efficiency in soft agar, allowing facile isolation of variant clones. Two hundred individual steroid-resistant clones of S49 cells have been isolated and analyzed to determine the origin of their resistance. Most of these variant clones (55 %) fail to bind [3H]dexamethasone at levels above background; 70--75 percent bind less than 30 % of the wild-type level. The remaining clones fall into three general groups with respect to the efficiency with which receptors are translocated to the nucleus following dexamethasone treatment: one class transfers less than 10 percent of labeled receptors to the nucleus, another transfers normal amounts, and a third localizes virtually all of the receptors in the nucleus. The four variant phenotypes have been respectively designated r-, receptor activity deficient; nt-, nuclear transfer deficient; d-, deathless (appears normal in binding and nuclear transfer); and nti, increased nuclear transfer. Physical characterization by sucrose gradient sedimentation and gel permeation chromatography reveals that wild-type receptors are approximately 90,000 daltons and nti receptors about 50,000 daltons. The affinities of variant and wild-type receptors for purified DNA in vitro are consistent with their respective nuclear binding characteristics in vivo. Genetic studies with these and other cell lines, combined with recently developed methods for purification and structural analysis of minute quantities of proteins, can provide the level of biochemical resolution required for a fundamental understanding of the molecular mechanism of steroid hormone action.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011965 Receptors, Glucocorticoid Cytoplasmic proteins that specifically bind glucocorticoids and mediate their cellular effects. The glucocorticoid receptor-glucocorticoid complex acts in the nucleus to induce transcription of DNA. Glucocorticoids were named for their actions on blood glucose concentration, but they have equally important effects on protein and fat metabolism. Cortisol is the most important example. Corticoid Type II Receptor,Glucocorticoid Receptors,Glucocorticoids Receptor,Corticoid II Receptor,Corticoid Type II Receptors,Glucocorticoid Receptor,Receptors, Corticoid II,Receptors, Corticoid Type II,Receptors, Glucocorticoids,Corticoid II Receptors,Glucocorticoids Receptors,Receptor, Corticoid II,Receptor, Glucocorticoid,Receptor, Glucocorticoids
D011987 Receptors, Steroid Proteins found usually in the cytoplasm or nucleus that specifically bind steroid hormones and trigger changes influencing the behavior of cells. The steroid receptor-steroid hormone complex regulates the transcription of specific genes. Corticosteroid Receptors,Receptors, Corticosteroid,Steroid Receptors,Corticosteroid Receptor,Receptors, Steroids,Steroid Receptor,Receptor, Corticosteroid,Receptor, Steroid,Steroids Receptors
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

C H Sibley, and K R Yamamoto
March 1988, Deutsche medizinische Wochenschrift (1946),
C H Sibley, and K R Yamamoto
September 1997, Molecular carcinogenesis,
C H Sibley, and K R Yamamoto
November 1989, Carcinogenesis,
C H Sibley, and K R Yamamoto
February 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
C H Sibley, and K R Yamamoto
January 1983, Bulletin europeen de physiopathologie respiratoire,
C H Sibley, and K R Yamamoto
May 1971, Journal of the National Cancer Institute,
C H Sibley, and K R Yamamoto
January 2003, In vivo (Athens, Greece),
C H Sibley, and K R Yamamoto
February 2019, Pharmacology & therapeutics,
C H Sibley, and K R Yamamoto
August 2000, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!